Markets & Regulations

© Getty Images

Nucleus RadioPharma secures Series A investment from AstraZeneca

By Isabel Cameron

Nucleus RadioPharma, a leading player in the development, manufacturing, and supply chain management of radiopharmaceuticals, has announced a significant milestone with the closing of a Series A extension round, featuring a new investment from AstraZeneca.

© Getty Images

Bio International 2024

Cytiva: 'BIO is a very important convention for us'

By Isabel Cameron

Life sciences business Cytiva is set to launch its new platform, designed to accelerate the manufacturing process for autologous CAR-T cell therapies. Find out more about the company's priorities, market challenges, expansion plans and more.

© Getty Images

Bio International 2024

Ecolab Life Sciences to unveil bioquell qube and more at BIO 2024

By Isabel Cameron

Ahead of Bio 2024, we caught up with Matt Cokely, global technical consultant strategic leader, and Helen Gates, marketing director, at Ecolab Life Sciences to find out what the company is planning for the event and how it is navigating current challenges...

© Getty Images

Bio International 2024

Novartis to showcase next-gen manufacturing solutions at BIO 2024

By Isabel Cameron

Before the industry is set to arrive in San Diego for Bio International 2024, we spoke with Dr. Harald Oberegger, global head business development at Novartis Contract Manufacturing. At the event, the company will be showcasing its cutting-edge technologies,...